Alexis Rolloff

Sharing my thoughts on how UC Davis Health is working to decrease costs by reducing unwarranted variations in patient care. Leveraging artificial intelligence to provide accurate and meaningful data to illustrate patients’ problems to clinicians will be key. As I noted in this article below: “AI has the power to aggregate vast amounts of data and demonstrate the impact of different care pathways, informing nurses and physicians about the optimal way to deliver care for each patient. With AI providing constant surveillance of practice variations, maybe it won’t take many years for improved care algorithms to make their way into daily practice. We need to align incentives with this to speed up the adoption of these more effective approaches to improved care.” https://lnkd.in/gjYfRJmD

59

1 Comment

As promised here are my thoughts from Day 2 at the FDA's Digital Health Advisory Committee meeting on "Total Product Lifecycle Considerations for Generative-AI Enabled Devices." I have pretty much focused my thoughts on the talk and remarks presented by Dr. Keith J. Dreyer as he summarized it all very eloquently. He was truly inspiring! Here are my top 5 takeaways: 1️⃣ Continuous Clinical Validation is a Must: AI devices, especially in radiology, need ongoing validation to ensure they remain accurate and effective in real-world settings. 2️⃣ Regulating Generative AI for Patient Safety: There's a pressing need for clear regulations to guide the safe deployment of GenAI in healthcare, focusing on transparency and human oversight. 3️⃣ Expanding the FDA's Role: Keith emphasized that the FDA should look beyond manufacturers to include device users for better monitoring. As he put it, "We have to keep the data pristine to make sure these devices are working, independent of what the manufacturer makes." 4️⃣ Cost-Effective Monitoring Solutions: Recognizing that monitoring and validation can be costly, we need innovative solutions that make this feasible for all healthcare settings, big or small. 5️⃣ AI's Potential to Boost Efficiency: Generative AI could greatly enhance efficiency in radiology. Keith noted, "If there was a way to improve our efficiency through AI, and I think Gen AI has a way to be able to do that, then you're going to see availability, much broader availability of even specialists, to do more work and to work beyond the scope of what they can do today." I'm thrilled to be part of these vital conversations and can't wait to continue exploring how we can responsibly harness AI to transform healthcare! Here is the link to Dr. Keith J. Dreyer's talk: https://lnkd.in/gFisjcXW #GenerativeAI #AIinHealthcare #DigitalHealth FDA #PatientSafety #ClinicalValidation HOPPR American College of Radiology

86

4 Comments

Equitable healthcare stands as the paramount goal for the industry, especially in an era where patient demands outpace available resources. While advancements have propelled healthcare to unprecedented heights, the widening gap between patient needs and resource availability poses a daunting challenge. However, AI emerges as a powerful ally in bridging this disparity. Here’s how: #Healthcare #AI #PatientCare

12

Just two years ago, Walgreens Boots Alliance (WBA) was being hailed as the next big thing in healthcare at conferences like HLTH and J.P. Morgan Health. Their big plans to combine primary care, in-home care, and pharmacy services were going to "revolutionize healthcare." As Roz Brewer, CEO of WBA, confidently stated at HLTH 2022: “Healthcare is local, and most times healthcare happens outside of the current health system. We have the ability to take our relationship between the pharmacist and the consumer, combine that with the primary care that VillageMD delivers, and the in-home care that CareCentrix offers… and we can patch together a continuum of care and deliver healthcare services through a brand that everyone knows and trusts.” Brewer highlighted investments in VillageMD, CareCentrix, and Shields Health Solutions as key to building this “continuum of care,” leveraging nearly 9,000 stores to bring healthcare services to people's doorsteps. John Driscoll, EVP and President of U.S. Healthcare, added: “We will continue to invest in, expand and leverage partnerships with entrepreneurs throughout the healthcare system because we know that with our 86,000 healthcare providers along with our partners, we can provide a more accessible and better-connected experience for patients.” Fast forward and it's a completely different story. Walgreens is shutting down stores and scaling back its healthcare ventures. The latest financial results for Walgreens Boots Alliance show significant losses and unmet expectations. The Wall Street Journal and other outlets have detailed the decline. And it's not just Walgreens. Big players like CVS and Walmart have also pumped huge sums into primary care and digital health, only to watch these investments fall short and cut their losses. The truth is, we can't expect corporations like CVS, Walmart, or Walgreens to solve our healthcare woes. Why? If a healthcare solution doesn’t align perfectly with their financial model, it’s doomed from the start. Healthcare is fundamentally local, and these giant corporations simply aren’t. They lack the ability to tailor their services to the unique needs of different communities. What's missing from these grand strategies? Understanding that healthcare models need to be customized for specific populations. Few organizations have effectively used data and analytics to address unique needs, and the crucial provider-patient relationship is overlooked in large-scale corporate plans. Moral of the story? HLTH may not be worth the investment if you're looking for good predictors of success. And... a more localized, patient-focused approach is necessary to truly transform healthcare. *Credit to Jeffrey Hogan for highlighting the HLTH connection. Brian KlepperAl Lewis 🇺🇦Alex JungLee LewisShawn Gremminger John TozziAnn M. Richardson, MBA

81

35 Comments

Here’s your recap of last week’s health IT news 🗞️ 👇 🤖 AI Clinician Assistant • athenahealth released Ambient Notes, a fully integrated AI ambient scribe for ambulatory practices, which also supports switching between AI models based on context and individual preference. • Abridge is partnering with OpenNotes to evaluate AI-generated visit summaries. 📞 AI Contact Center • healow health released Genie, a phone-, text-, and chat-based AI conversational chat solution for appointment scheduling, prescription refills, and more. 🏥 AI Facility Management • Kontakt.io released a security app that allows staff to page security personnel with location information, and a Kio Nurse app for locating items with a live map view. 📈 Data & Analytics • Alameda County selected Innovaccer to unify and analyze the data in its Social Health Information Exchange.    • Cornerstone AI announced an additional $5M investment, bringing its total funding to $10M. • emtelligent released their Clinical Workflows solution, which offers both clinical and business users across healthcare organizations an interface experience to interact with their existing LLM and NLP engine. 💼 Provider & Practice Administration • Axuall announced two new health system partnerships—VA-based Inova Health System and IN-based Community Health Network—and a partnership with PayrHealth, which helps providers negotiate contracts and reimbursements. 🔁 RCM • SmarterDx released an AI denials solution that creates AI-generated appeals letters.    • Inovalon hosted its Empower 2024 summit and announced a host of new solutions and updates, including an eligibility verification solution for provider organizations and several other tools for health plans and research organizations. • XiFin, Inc. added two new payers to its Payor Rate Transparency Monitor—Humana and Blue Shield of California—and launched Payor Intelligence Hub to help providers better understand payer policies and behaviors. ⚙️ Clinical Operations • Oracle hosted its Oracle Health Summit and announced a number of new features and product updates, including an AI-native EHR, patient admin tools, and plans to become a QHIN. • eClinicalWorks hosted its National Conference and released AI RCM tools, VBC scorecards, and patient engagement updates. • Altera Digital Health released a new EHR, Paragon Denali—natively deployed in Microsoft Azure —intended for rural, critical access, and community hospitals. 🤝 Staffing, Consults, and Referrals: • Tennr raised a $37M Series B. • Cottage Hospital partnered with ShiftMed to add more flexible per diem options for acute care staff. 🧑‍💻 Virtual & At-Home Care • Brook Health is partnering with Linus Health to provide treatment plans and ongoing remote clinical care for cognitive care patients. --- Want the latest healthcare tech news delivered to your inbox each week? Sign up here 📬 👉 https://lnkd.in/e2UJ3ckP

44

1 Comment

***From Best Practices to Next Practices*** This article from Jon Warner and Jomo Kenneth Starke discusses the shift from Return on Investment (ROI) to Return on Value (ROV) in healthcare, emphasizing a holistic approach that includes innovation, impact, and investment returns. ​ ROV considers qualitative factors alongside financial gains, guiding organizations to align investments with their missions. ​ It encourages long-term perspectives, justifying patient capital for incremental value creation. ​ Challenges in quantifying non-financial returns are acknowledged, but the benefits of ROV outweigh them. ​ This framework aids in strategic decision-making, resource allocation, and partnership formation to maximize value for individuals and society. ​ #Healthcare #ReturnOnValue #Innovation #PatientOutcomes #Collaboration #nextgen #valueovervolume https://lnkd.in/gihZBhSY

27

8 Comments

This is certainly an interesting development. While Envision leaving California might resolve the issues at hand, the imperatives driving scrutiny of PE-backed enterprises are not going away any time soon. There many concerns voiced in the late 1990's as well, during the PPM boom, but in this case, I sincerely don't think we'll see anything close to the retrenchment we saw in the early 2000's. I also think it's easy for some people to point fingers at PE (and there have admittedly been reasons for concern with some enterprises), but financial incentives can theoretically interfere with the care process exists in almost every context I can imagine, regardless of ownership. So where do we draw the line about what improperly interferes with a physician's independent medical judgment and the best interests of a patient? I, for one, don't believe that it's appropriate to paint all PE enterprises with the same brush, just like it's unfair to compare rural critical access hospitals to major academic teaching hospitals without understanding the differences.

4

"Consumers are more motivated than ever to choose healthcare options that offer a better experience, higher quality of care, and greater value. As the shift to consumerism continues, organizations that embrace it most successfully will emerge as leaders of the healthcare ecosystem. In the near term—beyond benefits to consumer experience and care—developing a distinctive consumer experience could translate to financial gains through increased acquisition, retention, and share of engagement; reduced administrative costs; and improved Consumer Assessment of Healthcare Providers and Systems (CAHPS) and Medicare Advantage Star ratings.” https://lnkd.in/gQBAzSWM

11

Do you ever wonder why health technology and therapy consumers make the decisions they do? I'm eager to hear how Roundpeg Consulting, LLC has leveraged MRI-Simmons' consumer insights to provide value to organizations and leaders across various sectors of healthcare. #Healthcare #B2C #Leaders #Consumer #HealthTechnology

10

🚀 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲: 𝗕𝗹𝘂𝗲 𝗦𝗵𝗶𝗲𝗹𝗱’𝘀 𝗕𝗼𝗹𝗱 𝗠𝗼𝘃𝗲 🚀 𝗕𝗹𝘂𝗲 𝗦𝗵𝗶𝗲𝗹𝗱’s recent move to 𝗽𝘂𝗿𝗰𝗵𝗮𝘀𝗲 𝗛𝘂𝗺𝗶𝗿𝗮 𝗯𝗶𝗼𝘀𝗶𝗺𝗶𝗹𝗮𝗿 directly from the manufacturer is a noteworthy shift in the healthcare landscape. 💊✨ Is this a trend for health plans? As we navigate through these transformative times, it’s clear that 𝗵𝗲𝗮𝗹𝘁𝗵 𝗽𝗹𝗮𝗻𝘀 are increasingly adopting 𝗼𝘂𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗯𝗼𝘅 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 to enhance care delivery and cost management. 📈🔍 𝗟𝗲𝘁’𝘀 𝗰𝗼𝗻𝗻𝗲𝗰𝘁 𝗮𝘁 𝘁𝗵𝗲 𝗙𝗶𝗲𝗿𝗰𝗲 𝗛𝗲𝗮𝗹𝘁𝗵 𝗣𝗮𝘆𝗲𝗿 𝗦𝘂𝗺𝗺𝗶𝘁 𝘁𝗼 𝗱𝗶𝘀𝗰𝘂𝘀𝘀 𝘁𝗵𝗶𝘀 𝗮𝗻𝗱 𝗼𝘁𝗵𝗲𝗿 𝗽𝗿𝗲𝘀𝘀𝗶𝗻𝗴 𝘁𝗼𝗽𝗶𝗰𝘀! 𝗙𝗼𝗼𝗱 𝗳𝗼𝗿 𝘁𝗵𝗼𝘂𝗴𝗵𝘁: How will this shift impact medical management operational spend? What about clinical staffing gaps and shortages? How will the prior authorization (PA) process be effected now that the middleman is out of the picture? 🤔💬 #HealthcareInnovation #BlueShield #FierceHealthcare #FierceHealthPayerSummit #MedicalManagement #UtilizationManagement #ValueBasedCare #HealthPlans #PatientCentricCare #HealthcareTrends #PharmacyBenefitManagement #FutureOfHealthcare https://lnkd.in/ejuESVZE

4

Key trends and takeaways from HLTH 2024: 1. AI's Evolving Role: AI dominated discussions, with executives acknowledging its potential while also recognizing challenges in accuracy and clinician trust. There's a shift towards focusing on the practical applications of AI, with a call for partnerships to ensure reliable testing and implementation. 2. Infrastructure Focus: Beyond the glitzy AI tools, there's a growing emphasis on the "picks and shovels" needed for healthcare data accessibility, including infrastructure, compliance, and interoperability. Executives believe that improving data flow will facilitate the effective use of AI. 3. Middlemen Under Scrutiny: Pharmacy benefits managers (PBMs) faced criticism for their role in rising drug costs, with discussions highlighting misaligned incentives and the need for transparency in healthcare pricing. 4. Women's Health Spotlight: Women's health initiatives gained attention, particularly following government funding announcements and personal stories shared by advocates. However, investment in women's health remains minimal compared to overall healthcare funding. 5. Interest in Psychedelic Medicine: The potential of psychedelics for treating mental health conditions garnered significant interest, with discussions about funding and research moving forward, especially within the Veterans Affairs system. Executive Takeaways: Leaders from various sectors emphasized the importance of consumer-focused strategies, collaboration, and the need for responsible AI usage. There was a consensus on the critical role of addressing healthcare accessibility, improving patient experiences, and fostering innovations that genuinely enhance care delivery.

2

Nice sum up on the #privateequity investments in #healthcareservices “healthcare services are increasingly integrating technology into workflows and becoming more attractive to tech investors” - Dan Shoenholz Private Equity Leader at EY-Parthenon. Technology has immense potential to amp up the quality of care, access and bridge gaps created by labor shortages through AI, automation and richer data science prediction tools.

8

🤖 AI in the Boardroom: Hype or Opportunity?🚀 At this year’s NACD (National Association of Corporate Directors) Summit the conversation around AI and its rapid impact on business is front and center. The potential for AI to transform industries is undeniable—but is it all just hype, or are we on the brink of a business revolution? 🏢💡 Boards are now being challenged to understand AI's role in driving long-term value, balancing the excitement with governance and risk management. How do we separate the true opportunities from the noise? 🌐⚖️ Whether enhancing decision-making, improving operational efficiency, or creating new revenue streams, AI has incredible promise. But it’s up to board members to ensure its responsible integration into strategy. What are your thoughts? Hype or opportunity? Let’s keep the conversation going! 💬 Check out Blue Ribbon Commission Reprt chaired by Nora M. Denzel and David Kenny below 👇🏽 #NACDSummit #AI #BoardLeadership #CorporateGovernance #EmergingTech #BusinessStrategy #GovernanceInnovation https://lnkd.in/gqSXgubA

17

1 Comment

HTI-2 is here. Laboratories will want to take note as there are requirements for use of Laboratory Orders Interfacing (HL7 version 2.5.1) and Laboratory Results Interfacing (HL7 version 2.5.1) for public health reportables (ELR). If you don't yet have HL7 2.5.1 interfaces with trading partners (paper, fax, HL7 version 2.3.1, etc) you should make plans to update interfaces soon. This impacts both senders and receivers of laboratory data. If you are a pathology laboratory, this may impact you if you perform any public health reportables like Creutzfeldt-Jakob Disease(CJD) as it is reportable in many jurisdictions. ONC has webinars. EHR vendors, providers, and those performing specimen collections will want to ensure they send complete information such as Specimen Type, Specimen collection procedures, Specimen Source site and other Ask at Order Entry (AOE) details required by the performing laboratory and/or public health for reportables.

16

1 Comment

I am grateful to Medical Economics for inviting me to explore the important topic of whether healthcare is shifting toward viewing the patient in the same light as a consumer. This conversation is crucial as we witness a significant evolution in the healthcare industry, where patient-centric approaches are becoming the norm. I am proud of the work we are doing at OneStep for the team's relentless focus on patient centricity. Healthcare is increasingly focusing on empowering patients, making health tech solutions more accessible and relevant. This shift not only improves patient outcomes and satisfaction but also fosters stronger engagement between patients and healthcare providers. By prioritizing patient needs, we are setting the stage for a more efficient and patient-focused future. #healthcare #healthtech #healthcareinnovation #patientcare #patientcentered #patientsatisfaction

12

1 Comment